This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Arch Capital (ACGL) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Arch Capital's (ACGL) third-quarter earnings are likely to have benefited from Mortgage insurance business and better pricing while cat loss is likely to have weighed on results.
What's in the Cards for Chubb (CB) This Earnings Season?
by Zacks Equity Research
Chubb's (CB) Q3 performance is likely to have benefited from premium growth, expanded invested assets and a solid market presence.
What's in Store for Everest Re (RE) This Earnings Season?
by Zacks Equity Research
Everest Re (Re) is likely to have gained from solid performance of both the Reinsurance and Insurance segment and lower expenses in the third quarter.
Allstate (ALL) to Report Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Allstate (ALL) Q3 earnings are likely to have benefited from increase in premium and share buyback.
Why Chubb (CB) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Chubb (CB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Progressive (PGR) Q3 Earnings Surpass Estimates, Down Y/Y
by Zacks Equity Research
Progressive (PGR) Q3 earnings reflect improvement in premiums.
Chubb (CB) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Chubb (CB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The Zacks Analyst Blog Highlights: JPMorgan, CME, Chubb, S&P Global and Ford
by Zacks Equity Research
The Zacks Analyst Blog Highlights: JPMorgan, CME, Chubb, S&P Global and Ford
Top Analyst Reports for JPMorgan, CME Group & Chubb
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase (JPM), CME Group (CME) and Chubb (CB).
Reasons Why Investors Should Retain Chubb in Their Portfolio
by Zacks Equity Research
Chubb Limited (CB) is poised to grow given its strategic growth initiatives and solid capital position.
P&C Insurance Industry's Near-Term Prospects Encouraging
by Tanuka De
The property and casualty insurance industry remains well poised on better pricing, solid policyholders' surplus and increasing use of technology.
What Makes Allstate (ALL) an Attractive Investment Option
by Zacks Equity Research
Allstate's (ALL) well-performing Property and Casualty segment and growing Service business poise it well for growth.
Why Is Chubb (CB) Up 2.2% Since Last Earnings Report?
by Zacks Equity Research
Chubb (CB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Aflac Rides on Strong U.S. Business and Solid Balance Sheet
by Zacks Equity Research
Aflac's (AFL) favorable U.S business, changes in Japan business and a strong balance sheet are likely to aid its long-term growth.
Allstate (ALL) Estimates Weather Related Losses in July
by Zacks Equity Research
Allstate (ALL) expects to incur $223 million pre-tax catastrophe loss for July, which can be attributed to 10 weather-related events.
Top Research Reports: Bristol-Myers, CME Group, Chubb & More
by Kalyan Nandy
Today's Research Daily features updated research reports on 16 major stocks, including Bristol-Myers (BMY), CME Group (CME) and Chubb (CB).
MetLife (MET) Q2 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
MetLife's (MET) second-quarter earnings benefit from lower expenses, partly offset by decline in revenues.
Allstate (ALL) Beats on Q2 Earnings and Revenues, Up Y/Y
by Zacks Equity Research
Allstate's (ALL) Q2 earnings benefit from increase in premium, partly offset by catastrophe losses.
Chubb's (CB) Earnings Beat Estimates in Q2, Decrease Y/Y
by Zacks Equity Research
Chubb's (CB) second-quarter earnings gain from higher premium revenues.
Chubb (CB) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Chubb (CB) delivered earnings and revenue surprises of 0.78% and 12.14%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Why Chubb (CB) Might Surprise This Earnings Season
by Zacks Equity Research
Chubb (CB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Chubb (CB) to Report Q2 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Chubb's (CB) second quarter earnings is likely to benefit from increased scale, improved commercial property and casualty pricing and prudent underwriting.
RLI Corp.'s (RLI) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
RLI Corp.'s (RLI) Q2 results reflect improved premiums across most of its product lines along with increase in net investment income.
Travelers (TRV) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Travelers (TRV) Q2 is likely to benefit from increase in premiums, successful execution of marketplace strategies and a benign cat environment.
Progressive (PGR) Q2 Earnings Beat, Increase Year Over Year
by Zacks Equity Research
Progressive's (PGR) second quarter results reflect improvement in revenues offset the increase in expense.